Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | FDPS | P14324 | 6/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8467475 | 0.81 | CYP3A4 (0.47) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL2583732 | 0.77 | CYP3A4 (0.47) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL9154488 | 0.76 | CYP3A4 (0.46) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL7539306 | 0.74 | CYP3A4 (0.44) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL4446174 | 0.74 | ALDH1A1 (0.47) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL8467900 | 0.74 | ALDH1A1 (0.47) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL15153014 | 0.73 | ALDH1A1 (0.45) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| Phosphine SCHEMBL27074301 | 0.73 | ALDH1A1 (0.45) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL27296353 | 0.73 | ALDH1A1 (0.45) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 | |
| SCHEMBL27324354 | 0.73 | ALDH1A1 (0.45) | CYP3A4L3MBTL1ALDH1A1FDPSCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0524942-B1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | LYNX THERAPEUTICS INC (US) | 1998-04-15 | — | — | EP | disclosed |
| US-5292875-A | Method of synthesizing sulfurized oligonucleotide analogs | LYNX THERAPEUTICS, INC. (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0524942-A4 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | — | 1993-07-21 | — | — | EP | disclosed |
| EP-0524942-A1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | LYNX THERAPEUTICS, INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| US-5151510-A | METHOD OF SYNETHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | APPLIED BIOSYSTEMS, INC. (US) | 1992-09-29 | — | — | US | disclosed |
| WO-1991016331-A1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | APPLIED BIOSYSTEMS, INC. (US) | 1991-10-31 | — | — | WO | disclosed |